RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of RSLS
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Tuesday for ReShape Lifesciences Inc stock after losing 3.17%
(Updated on Jul 02, 2024)

Sell candidate since Jul 01, 2024 Loss -3.17% PDF

The ReShape Lifesciences Inc stock price fell by -3.17% on the last day (Tuesday, 2nd Jul 2024) from $0.199 to $0.193. During the last trading day the stock fluctuated 4.14% from a day low at $0.191 to a day high of $0.199. The price has fallen in 5 of the last 10 days and is down by -6.37% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -42 thousand shares and in total, 205 thousand shares were bought and sold for approximately $39.44 thousand.

Given the current short-term trend, the stock is expected to rise 23.22% during the next 3 months and, with a 90% probability hold a price between $0.237 and $0.371 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

RSLS Signals & Forecast

There are few to no technical positive signals at the moment. The ReShape Lifesciences Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.197 and $0.205. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, May 29, 2024, and so far it has fallen -31.18%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for ReShape Lifesciences Inc stock

ReShape Lifesciences Inc finds support from accumulated volume at $0.185 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0079 between high and low, or 4.14%. For the last week the stock has had daily average volatility of 6.22%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RSLS) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect ReShape Lifesciences Inc to open at $0.194, and during the day (based on 14 day Average True Range), to move between $0.167 and $0.219, which gives a possible trading interval of +/-$0.0262 (+/-13.57%) up or down from last closing price. If ReShape Lifesciences Inc takes out the full calculated possible swing range there will be an estimated 27.15% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.195 (1.35%) than the support at $0.185 (3.89%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is ReShape Lifesciences Inc stock A Buy?

The ReShape Lifesciences Inc stock holds several negative signals and despite the positive trend, we believe ReShape Lifesciences Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.487 Sell Candidate Unchanged

Predicted Opening Price for ReShape Lifesciences Inc of Wednesday, July 3, 2024

Fair opening price July 3, 2024 Current price
$0.194 ( 0.778%) $0.193

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for RSLS

Fibonacci Support & Resistance Levels

Level Price
R3 0.202 4.88%
R2 0.199 3.31%
R1 0.197 2.34%
Price 0.193
S1 0.191 -0.788%
S2 0.189 -1.76%
S3 0.186 -3.32%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.211 9.39%
R2 0.197 1.97%
R1 0.195 1.35%
Price 0.193
S1 0.185 -3.89%
S2 0.176 -8.56%
S3 0.175 -9.19%

FAQ

What is the symbol for ReShape Lifesciences Inc Stock and on which exchange is it traded?
The symbol for ReShape Lifesciences Inc is RSLS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ReShape Lifesciences Inc Stock?
The ReShape Lifesciences Inc stock holds several negative signals and despite the positive trend, we believe ReShape Lifesciences Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy ReShape Lifesciences Inc Stock?
ReShape Lifesciences Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ReShape Lifesciences Inc Stock.

What's the current price of ReShape Lifesciences Inc Stock?
As of the end of day on the Jul 02, 2024, the price of an ReShape Lifesciences Inc (RSLS) share was $0.193.

What is the 52-week high and low for ReShape Lifesciences Inc Stock?
The 52-week high for ReShape Lifesciences Inc Stock is $1.66 and the 52-week low is $0.141.

What is the market capitalization of ReShape Lifesciences Inc Stock?
As of the Jul 02, 2024, the market capitalization of ReShape Lifesciences Inc is 4.668M.

When is the next earnings date for ReShape Lifesciences Inc?
The upcoming earnings date for ReShape Lifesciences Inc is Aug 05, 2024.
Click to get the best stock tips daily for free!

About ReShape Lifesciences Inc

ReShape Lifesciences ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investi... RSLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT